Advanced company searchLink opens in new window

INPHARM HOLDCO LTD

Company number 14272464

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
27 Feb 2024 GAZ2(A) Final Gazette dissolved via voluntary strike-off
12 Dec 2023 GAZ1(A) First Gazette notice for voluntary strike-off
29 Nov 2023 DS01 Application to strike the company off the register
25 Sep 2023 SH01 Statement of capital following an allotment of shares on 14 September 2023
  • EUR 1.0001
21 Aug 2023 CS01 Confirmation statement made on 2 August 2023 with updates
02 Aug 2023 AD01 Registered office address changed from Suite 1, 7th Floor 50 Broadway London SW1H 0BL United Kingdom to Devonshire House 1 Mayfair Place C/O Letterone London W1J 8AJ on 2 August 2023
02 Aug 2023 TM02 Termination of appointment of Vistra Cosec Limited as a secretary on 31 July 2023
23 Feb 2023 AD01 Registered office address changed from Suite 1, 3rd Floor 11 - 12 st James's Square London SW1Y 4LB United Kingdom to Suite 1, 7th Floor 50 Broadway London SW1H 0BL on 23 February 2023
22 Feb 2023 PSC08 Notification of a person with significant control statement
22 Feb 2023 PSC07 Cessation of Mubashir Mukadam as a person with significant control on 11 February 2023
13 Feb 2023 AP01 Appointment of Philip Christoph Urs Buergin as a director on 10 February 2023
13 Feb 2023 TM01 Termination of appointment of Barclay Jackson Morison as a director on 10 February 2023
03 Aug 2022 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)

Statement of capital on 2022-08-03
  • EUR 1